Full View

Hematopoietic stem cell transplantation for patients with AML in first complete remission

JJ Cornelissen, D Blaise - Blood, The Journal of the American …, 2016 - ashpublications.org
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …
被引用次数：354 相关文章

Hematopoietic stem cell transplantation for patients with AML in first complete remission

JJ Cornelissen, D Blaise - Blood, 2016 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Postremission therapy in patients with acute
myeloid leukemia (AML) may consist of continuing chemotherapy or transplantation using …

Hematopoietic stem cell transplantation for patients with AML in first complete remission.

JJ Cornelissen, D Blaise - Blood, 2015 - europepmc.org
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …

Hematopoietic stem cell transplantation for patients with AML in first complete remission

JJ Cornelissen, D Blaise - Blood, 2016 - pubmed.ncbi.nlm.nih.gov
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …
[HTML] sciencedirect.com

[HTML][HTML] Hematopoietic stem cell transplantation for patients with AML in first complete remission

JJ Cornelissen, D Blaise - Blood, 2016 - Elsevier
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …

Hematopoietic stem cell transplantation for patients with AML in first complete remission

J Cornelissen, D Blaise - Blood, 2016 - repub.eur.nl
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …